(Q40451365)

20 September 2017

title

Apoptosis in ibuprofen-induced Stevens-Johnson syndrome. (English)

1 reference

20 September 2017

Manuela Neuman

1

1 reference

20 September 2017

Michael Nicar

series ordinal

2

1 reference

20 September 2017

publication date

1 May 2007

1 reference

20 September 2017

published in

Translational Research

1 reference

20 September 2017

volume

149

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

254-259

1 reference

Drug metabolism, danger signals, and drug-induced hypersensitivity

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Frequency and cost of serious adverse drug reactions in a department of general medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Toxic epidermal necrolysis: an eruption resembling scalding of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Toxic epidermal necrolysis (the scalded skin syndrome): A reappraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Idiosyncratic drug reactions: the reactive metabolite syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Idiosyncratic drug reactions: a mechanistic evaluation of risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Adverse drug reactions: mechanisms and assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

A novel lymphocyte toxicity assay to assess drug hypersensitivity syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Apoptosis in diseases of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Monitoring adverse drug reactions to sulfonamide antibiotics in human immunodeficiency virus-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Tumor necrosis factor, other cytokines and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

Interleukin-10 and related cytokines and receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2006.12.005

10.1016/J.TRSL.2006.12.005

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference